Important News and Updates

Updated September 6, 2019

Page Contents:

  1. We have moved!
  2. Recent FDA Guidance
  3. Recent FDA Draft Guidance

 


We have moved!

The administrative office for the Regulatory Affairs and Clinical Trials Office has moved from the Research Administration Building to the Dalney Street Building.  Our new address is listed below:

 

Office of Research Integrity Assurance

Georgia Institute of Technology
Dalney Street Building
926 Dalney St, NW Atlanta, GA 30318

 


Recent FDA Guidance

The Food and Drug Administration (FDA) continuosly releases guidance documents to inform the public of the Agency's current thinking on a particular subject.  These guidance documents are not binding, but are considered to be best practice.  Below is a list of the latest guidance from the FDA.  The most current list can be found on the FDA's website.

 


 

Recent FDA Draft Guidance

The Food and Drug Administration (FDA) continuosly releases guidance documents to inform the public of the Agency's current thinking on a particular subject.  These guidance documents are not binding, but are considered to be best practice.  Draft guidance is different from final guidance, in that these document are open for public comment.  The FDA then can use the public comment to update or revise the guidance  prior to establishing a final guidance document.  Below is a list of the latest draft guidance from the FDA.  The most current list can be found on the FDA's website.